
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.110 | 48.370 | 42.260 |
Bonds | 90.310 | 90.310 | 0.000 |
Convertible | 2.010 | 2.010 | 0.000 |
Preferred | 0.660 | 0.660 | 0.000 |
Other | 0.910 | 0.950 | 0.040 |
Name | Net % | Category Average |
---|---|---|
Corporate | 90.056 | 86.495 |
Derivative | 0.074 | 18.666 |
Cash | 6.070 | 9.511 |
Securitized | 0.465 | 1.136 |
Government | 0.419 | 3.338 |
Number of long holdings: 356
Number of short holdings: 41
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nidda Healthcare Holding GmbH 5.625% | XS2920589699 | 1.51 | - | - | |
CPI Property Group S.A. 4.875% | XS1982704824 | 1.10 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 1.08 | - | - | |
Newday Bondco PLC 13.25% | XS2558411224 | 1.07 | - | - | |
Ardonagh Finco Ltd. 6.875% | XS2765406371 | 0.98 | - | - | |
LHMC Finco 2 S.a r.l. 7.25% | XS2059777594 | 0.95 | - | - | |
UBS Europ Fin Debt Sust EUR U-X Acc | LU2520351177 | 0.91 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 7.875% | XS2592804194 | 0.88 | - | - | |
Heimstaden Bostad AB 6.25% | XS2930588657 | 0.87 | - | - | |
Altice France S.A 5.875% | XS1859337419 | 0.83 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS Bond S Convert Global EUR P dis | 4.12B | -0.81 | -0.22 | 2.84 | ||
UBS Bond S Convert Global EUR Q dis | 4.12B | -0.58 | 0.69 | 3.73 | ||
UBS Lux Bond SICAV Convert Global q | 4.12B | -0.59 | 0.69 | 3.77 | ||
UBS Lux Bond SICAV Convert Global E | 4.12B | -0.36 | 1.63 | 4.75 | ||
UBS Bond S Convert Global EUR F Acc | 4.12B | -0.48 | 1.09 | 4.28 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review